approval
saveSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 0 trial initiationWashington University School of Medicine — asciminib hydrochloride (Phase 0 Trial Initiation)Apr 30, 2026 · 161d ago
- phase 2 initiationNovartis AG — asciminib hydrochloride (Phase II Trial Initiation)Apr 25, 2026 · 166d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalNov 25, 2025 · 317d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 2, 2025 · 371d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 29, 2024 · 709d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 29, 2024 · 709d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalAug 7, 2024 · 792d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalJun 18, 2024 · 842d ago
same company · ±60 days · 6
- approvalasciminib hydrochloride: SCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 29, 2021
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalDec 3, 2021
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalDec 3, 2021
- approvalinclisiran: LEQVIO (INCLISIRAN SODIUM) — FDA approvalDec 22, 2021
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalDec 22, 2021
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalDec 22, 2021
🐶 often sniffed alongside
top 7- drugSCEMBLIX46 co-mentions · 13 sources
- tagApproval44 co-mentions · 11 sources
- tagSmall Molecule22 co-mentions · 11 sources
- tagOncology3 co-mentions · 2 sources
- company$NVSNOVARTIS AG1 co-mentions · 1 sources
- company$NVSEFNOVARTIS AG1 co-mentions · 1 sources
- companyWashington University School of Medicine1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that